Skip to main content

Advertisement

SpringerLink
Log in

Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Backgrounds

This retrospective study was conducted to compare the clinical outcomes of radiofrequency ablation (RFA) with those of stereotactic body radiotherapy (SBRT) in patients with lung tumors.

Methods

Local tumor progression, adverse events, and overall survival were compared in patients who underwent either RFA or SBRT for a single lung tumor measuring 5 cm or smaller. This study was approved by the institutional review boards of two institutions. Informed consent was waived.

Results

During September 2009 to June 2012, 48 patients [30 males and 18 females, with a mean age ± standard deviation (SD) of 75.0 ± 7.5 years] underwent RFA at one institution and 47 patients (21 males and 26 females, with a mean age ± SD of 77.0 ± 7.5 years) underwent SBRT in another. The mean maximum tumor diameter ± SD was 2.0 ± 0.8 cm (range 0.6−3.9 cm) in the RFA group, and 2.1 ± 0.9 cm (range 0.8–4.7 cm, p = 0.539) in the SBRT group. The RFA and SBRT groups showed similar 3-year local tumor progression [9.6 %, 95 % confidence interval (CI) 3.6–23.9 % vs. 7.0 %, 95 % CI 0.2–20.2 %, p = 0.746] and overall survival rates (86.4 %, 95 % CI 69.2–94.3 % vs. 79.6 %, 95 % CI 60.6–90.1 %, p = 0.738). No factor significantly affected local tumor progression. A maximum tumor size of 2 cm was identified as a prognostic factor in both univariate and multivariate analyses. No death was related to treatment procedures. Major complication rates (Grade 3 adverse events) of the RFA (10.4 %, 5/48) and SBRT (8.5 %, 4/47, p > 0.999) groups were similar.

Conclusion

For lung tumor patients, lung RFA provided local tumor control and survival that were similar to those achieved using SBRT, with equal safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Parkin DM, Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol. 2:533–543

    Article  CAS  PubMed  Google Scholar 

  2. Asamura H, Goya T, Koshiishi Y, Japanese Joint Committee of Lung Cancer Registry et al (2008) A Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3:46–52

    Article  PubMed  Google Scholar 

  3. Goldstraw P, Crowley J, Chansky K, International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2:706–714

    Article  PubMed  Google Scholar 

  4. Mery CM, Pappas AN, Bueno R et al (2005) Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 128:237–245

    Article  PubMed  Google Scholar 

  5. Uematsu M, Shioda A, Suda A et al (2001) Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51:666–670

    Article  CAS  PubMed  Google Scholar 

  6. Onishi H, Araki T, Shirato H et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101:1623–1631

    Article  PubMed  Google Scholar 

  7. Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290–3296

    Article  PubMed  Google Scholar 

  8. Timmerman R, Paulus R, Galvin J et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070–1076

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Shibamoto Y, Hashizume C, Baba F et al (2012) Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer 118:2078–2084

    Article  PubMed  Google Scholar 

  10. Haasbeek CJA, Lagerwaard FJ, Antonisse ME et al (2010) Stage I non-small cell lung cancer in patients aged >75 years: outcomes after stereotactic radiotherapy. Cancer 116:406–414

    Article  PubMed  Google Scholar 

  11. Takeda A, Sanuki N, Kunieda E et al (2009) Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys 73:442–448

    Article  PubMed  Google Scholar 

  12. Nagata Y, Takayama K, Matsuo Y et al (2005) Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427–1431

    Article  PubMed  Google Scholar 

  13. Koto M, Takai Y, Ogawa Y et al (2007) A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85:429–434

    Article  PubMed  Google Scholar 

  14. Grutters JP, Kessels AG, Pijls-Johannesma M et al (2010) Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 95:32–40

    Article  CAS  PubMed  Google Scholar 

  15. Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–275

    Article  PubMed  Google Scholar 

  16. Hiraki T, Gobara H, Iishi T et al (2007) Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 134:1306–1312

    Article  PubMed  Google Scholar 

  17. Beland MD, Wasser EJ, Mayo-Smith WW et al (2010) Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254:301–307

    PubMed  Google Scholar 

  18. Kodama H, Yamakado K, Takaki H et al (2012) Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol 35:563–569

    Article  PubMed  Google Scholar 

  19. Fernando HC, De Hoyos A, Landreneau RJ et al (2005) Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 129:639–644

    Article  PubMed  Google Scholar 

  20. Dupuy DE (2013) Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete? J Vasc Interv Radiol 24:1139–1145

    Article  PubMed  Google Scholar 

  21. Donington J, Ferguson M, Mazzone P, Thoracic Oncology Network of American College of Chest Physicians; Workforce on Evidence-Based Surgery of Society of Thoracic Surgeons et al (2012) American college of chest physicians and society of thoracic surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest 142:1620–1635

    Article  PubMed  Google Scholar 

  22. Howington JA, Blum MG, Chang AC et al (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e278S–e313S

    Article  CAS  PubMed  Google Scholar 

  23. Dunlap NE, Larner JM, Read PW et al (2010) Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT). J Thorac Cardiovasc Surg 140:583–589

    Article  PubMed  Google Scholar 

  24. Huang L, Han Y, Zhao J et al (2011) Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg 39:348–351

    Article  PubMed  Google Scholar 

  25. de Baère T, Palussière J, Aupérin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596

    Article  PubMed  Google Scholar 

  26. Timmerman R, McGarry R, Yiannoutsos C et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833–4839

    Article  PubMed  Google Scholar 

  27. Goldberg SN, Grassi CJ, Cardella JF, Society of Interventional Radiology Technology Assessment Committee; International Working Group on Image-Guided Tumor Ablation et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739

    Article  PubMed Central  PubMed  Google Scholar 

  28. Kashima M, Yamakado K, Takaki H et al (2011) Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. Am J Roentgenol 197:W576–W580

    Article  Google Scholar 

  29. Lee JM, Jin GY, Goldberg SN et al (2003) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125–134

    Article  PubMed  Google Scholar 

  30. Zhu JC, Yan TD, Glenn D et al (2009) Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg 87:1023–1028

    Article  PubMed  Google Scholar 

  31. Hiraki T, Tajiri N, Mimura H et al (2006) Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 241:275–283

    Article  PubMed  Google Scholar 

  32. Yamakado K, Akeboshi M, Nakatsuka A et al (2005) Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 28:530–532

    Article  PubMed  Google Scholar 

  33. Sakurai J, Hiraki T, Mukai T et al (2007) Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol 8:141–145

    Article  Google Scholar 

  34. Nomura M, Yamakado K, Nomoto Y et al (2008) Complications after lung radiofrequency ablation: risk factors for lung inflammation. Br J Radiol 81:244–249

    Article  CAS  PubMed  Google Scholar 

  35. Okuma T, Matsuoka T, Hamamoto S et al (2009) Percutaneous computed tomography-guided radiofrequency ablation of lung tumors complicated with idiopathic interstitial pneumonia. Ann Thorac Surg 87:948–950

    Article  PubMed  Google Scholar 

  36. Steinke K, Sewell PE, Dupuy D et al (2004) Pulmonary radiofrequency ablation—an international study survey. Anticancer Res 24:339–343

    PubMed  Google Scholar 

  37. Sano Y, Kanazawa S, Gobara H et al (2007) Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 109:1397–1405

    Article  PubMed  Google Scholar 

  38. Pennathur A, Abbas G, Gooding WE et al (2009) Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg 88:1601–1606

    Article  PubMed Central  PubMed  Google Scholar 

  39. Nagata Y, Hiraoka M, Mizowaki T et al (2009) Survey of stereotactic body radiation therapy in Japan by the Japan 3-D conformal external beam radiotherapy group. Int J Radiat Oncol Biol Phys 75:343–347

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

There is no conflict of interest, grant or any other assistance to be disclosed in any authors.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Matsusaka Central Hospital, 102 Kobou Kawaimachi, Matsusaka, Mie, 515-8566, Japan

    Satoru Ochiai

  2. Department of Radiology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan

    Koichiro Yamakado, Yoshihito Nomoto, Noriko Ii, Haruyuki Takaki & Hajime Sakuma

  3. Department of Radiology, Suzuka Central Hospital, 1275-53 Yamanohana Yasuduka-cho, Suzuka, Mie, 513-0818, Japan

    Hiroshi Kodama

Authors
  1. Satoru Ochiai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koichiro Yamakado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroshi Kodama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihito Nomoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noriko Ii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haruyuki Takaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hajime Sakuma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koichiro Yamakado.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ochiai, S., Yamakado, K., Kodama, H. et al. Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller. Int J Clin Oncol 20, 499–507 (2015). https://doi.org/10.1007/s10147-014-0741-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-014-0741-z

Keywords

Search

Navigation